FAQs
Fingerprint Drug Testing FAQs Explained
These fingerprint drug testing FAQs provide detailed answers to the most common operational, technical and compliance-related questions.
As a result, each answer is written to support confident, informed implementation. In addition, fingerprint testing complements existing drug testing policies and includes clear escalation pathways for non-negative results.
Collection
All ten fingertips are pressed onto the tamperproof cartridge to collect a sweat sample for analysis.
Analysis
The tamperproof cartridge is placed into the Intelligent Fingerprinting Drug Screening Portable Reader.
Results
Fast and accurate results available in under 10 minutes, displayed on the reader screen and printed using a Dymo printer.
What substances are detected by fingerprint drug testing?
Fingerprint Drug Testing screens for recent use of the following drug groups: Opiates, Cocaine, Methamphetamines and Cannabis (THC). Specifically, the screening cartridges are designed to detect drug metabolites present in fingertip sweat.
What is the typical detection window for substances?
Fingerprint Drug Testing typically detects substances used within the previous 16–24 hours. In some cases, however, cocaine may be detectable for up to 48 hours. This shorter detection window aligns with fitness-for-duty screening, therefore helping organisations identify recent use that may present an immediate safety risk, rather than historic lifestyle use.
How accurate is the test?
Fingerprint Drug Testing provides a reliable on-site screening method using fluorescent immunoassay technology. Results are classed as: Negative or Non-negative. Overall, accuracy is comparable to other point-of-care drug screening methods. As with all screening tests, however, results are not diagnostic and are therefore supported by confirmatory testing where required.
What does a ‘non-negative’ result mean?
A non-negative result indicates possible recent drug use. Importantly, it is not a confirmed positive result. In rail and other regulated environments, a non-negative result triggers a defined escalation process. This typically includes a RISQS-approved urine test or laboratory confirmation, in line with client policy and regulatory requirements.
Is fingerprint drug testing compliant with data protection laws?
Yes. Fingerprint Drug Testing is fully compliant with UK GDPR. Specifically, no biometric or fingerprint images are captured or stored. In addition, samples are anonymised using donor IDs and barcodes. Results are stored securely and accessed only by authorised personnel. As a result, the system protects individual privacy while maintaining full auditability. Overall, data handling is robust and transparent.
Can fingerprint testing be used in remote or mobile rail worksites?
Yes. The portable reader and cartridge system requires no plumbing, no private or gender-specific collection rooms, and no refrigeration. Consequently, it is well suited for use at depots, compounds, on-track locations and mobile worksites. In short, no specialist facilities are needed.
What if the donor is taking prescription or over-the-counter medication?
All prescription and over-the-counter medications must be declared during the consent process. If a non-negative result occurs, a Medical Review Officer (MRO) will therefore assess whether the declared medication could explain the result or impair the individual’s ability to perform safety-critical duties.
How are fingerprint drug test results recorded and reported?
Screening results are displayed on the portable reader within approximately 10 minutes. For audit and compliance purposes, result logs are stored on the device and can be recorded manually or printed. Furthermore, only non-negative results trigger escalation procedures. This therefore supports clear record-keeping without unnecessary administrative burden. In summary, the process is straightforward and audit-ready.
How long does the testing process take?
Sample collection takes under one minute per donor. Single tests provide results in around 10 minutes, while batch testing allows multiple individuals to be screened efficiently with minimal disruption to operations. For a full process overview, visit the How It Works page.
Does fingerprint drug testing create biohazardous waste?
No. Fingerprint Drug Testing is non-invasive and does not involve bodily fluids. As a result, there is no requirement for clinical waste disposal, making it cleaner and easier to manage on site.
Who can administer fingerprint drug tests?
Fingerprint drug tests can be administered by trained staff. Importantly, no medical background is required. Furthermore, training is provided to ensure correct use, consistent procedures and defensible results.
How do we implement fingerprint drug testing in our operation?
Implementation typically begins with an on-site or virtual demonstration. Auctus Management Group supports organisations with: setup and configuration, policy and consent documentation, administrator training and on-site rollout planning. As a result, the solution is deployed safely, consistently and in line with regulatory expectations.
Important note on rail compliance
While Network Rail currently mandates RISQS-approved urine testing for compliance-specific targets, these fingerprint drug testing FAQs highlight where FDT is well suited, including: Pre-employment screening, Site inductions, Random testing and Proactive safety screening on rail projects. It supports a safety-first culture while respecting existing regulatory frameworks.
Join our Satisfied Clients
Have more questions? Browse these fingerprint drug testing FAQs or discuss how we can support your organisation.
Mason Murphy, our fingerprint drug testing expert, is available to help, whether you have questions, need guidance, or are ready to explore next steps.
Richard Toy
CEO, Auctus MG